Table 2.
Change in score | 1997–1999 (Panel 1), % (SE) | 1999–2001 (Panel 2), % (SE) | 2001–2005 (Panel 3), % (SE) | |||
---|---|---|---|---|---|---|
PCPs (n = 4,025) | Specialists (n = 3,032) | PCPs (n = 5,104) | Specialists (n = 3,383) | PCPs (n = 2,352) | Specialists (n = 2,049) | |
Increased effect | 34.6 (0.8) | 31.2 (0.7) | 34.0 (0.9) | 35.0 (0.9) | 40.2 (1.4) | 40.2 (1.6) |
No change | 35.6 (0.6) | 35.2 (0.9) | 37.3 (1.0) | 34.2 (0.9) | 32.3 (1.7) | 32.1 (1.5) |
Decreased effect | 29.8 (0.8) | 33.6 (0.9) | 28.7 (0.8) | 30.7 (0.9) | 27.5 (1.6) | 27.6 (1.3) |
Data source: CTS Physician Survey panel data, 1997–2005
The reported value is the weighted absolute percentage of respondents whose score increased, did not change, or decreased.
The score indicates the change in respondents’ reported effect of CPGs on their clinical practice from one survey year to the next.